annual cash & cash equivalents:
$784.44M+$317.15M(+67.87%)Summary
- As of today (May 29, 2025), GMED annual cash & cash equivalents is $784.44 million, with the most recent change of +$317.15 million (+67.87%) on December 31, 2024.
- During the last 3 years, GMED annual cash & cash equivalents has risen by +$591.37 million (+306.30%).
- GMED annual cash & cash equivalents is now at all-time high.
Performance
GMED Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$461.27M-$323.17M(-41.20%)Summary
- As of today (May 29, 2025), GMED quarterly cash & cash equivalents is $461.27 million, with the most recent change of -$323.17 million (-41.20%) on March 31, 2025.
- Over the past year, GMED quarterly cash & cash equivalents has increased by +$107.20 million (+30.28%).
- GMED quarterly cash & cash equivalents is now -41.20% below its all-time high of $784.44 million, reached on December 31, 2024.
Performance
GMED quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMED Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.9% | +30.3% |
| 3 y3 years | +306.3% | +100.7% |
| 5 y5 years | +300.8% | +176.6% |
GMED Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +421.3% | -41.2% | +243.7% |
| 5 y | 5-year | at high | +421.3% | -41.2% | +243.7% |
| alltime | all time | at high | +1204.1% | -41.2% | +1009.9% |
GMED Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $461.27M(-41.2%) |
| Dec 2024 | $784.44M(+67.9%) | $784.44M(+26.0%) |
| Sep 2024 | - | $622.77M(+51.7%) |
| Jun 2024 | - | $410.42M(+15.9%) |
| Mar 2024 | - | $354.06M(-24.2%) |
| Dec 2023 | $467.29M(+210.6%) | $467.29M(+67.1%) |
| Sep 2023 | - | $279.62M(-8.8%) |
| Jun 2023 | - | $306.45M(+40.8%) |
| Mar 2023 | - | $217.69M(+44.7%) |
| Dec 2022 | $150.47M(-22.1%) | $150.47M(+12.1%) |
| Sep 2022 | - | $134.22M(-11.0%) |
| Jun 2022 | - | $150.77M(-34.4%) |
| Mar 2022 | - | $229.79M(+19.0%) |
| Dec 2021 | $193.07M(-19.4%) | $193.07M(-46.6%) |
| Sep 2021 | - | $361.88M(+34.6%) |
| Jun 2021 | - | $268.78M(+45.4%) |
| Mar 2021 | - | $184.85M(-22.8%) |
| Dec 2020 | $239.40M(+22.3%) | $239.40M(-4.5%) |
| Sep 2020 | - | $250.61M(+51.4%) |
| Jun 2020 | - | $165.55M(-0.7%) |
| Mar 2020 | - | $166.74M(-14.8%) |
| Dec 2019 | $195.72M(+40.2%) | $195.72M(+17.8%) |
| Sep 2019 | - | $166.09M(+41.0%) |
| Jun 2019 | - | $117.79M(-9.4%) |
| Mar 2019 | - | $129.98M(-6.9%) |
| Dec 2018 | $139.65M | $139.65M(-3.9%) |
| Sep 2018 | - | $145.29M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $119.94M(+0.1%) |
| Mar 2018 | - | $119.84M(+0.9%) |
| Dec 2017 | $118.82M(+77.5%) | $118.82M(-23.3%) |
| Sep 2017 | - | $154.85M(+3.5%) |
| Jun 2017 | - | $149.67M(-18.0%) |
| Mar 2017 | - | $182.44M(+172.5%) |
| Dec 2016 | $66.95M(+11.3%) | $66.95M(-25.8%) |
| Sep 2016 | - | $90.19M(-5.4%) |
| Jun 2016 | - | $95.34M(+17.3%) |
| Mar 2016 | - | $81.28M(+35.1%) |
| Dec 2015 | $60.15M(-26.9%) | $60.15M(+19.1%) |
| Sep 2015 | - | $50.50M(+21.5%) |
| Jun 2015 | - | $41.56M(-44.6%) |
| Mar 2015 | - | $75.01M(-8.8%) |
| Dec 2014 | $82.27M(-8.6%) | $82.27M(-51.5%) |
| Sep 2014 | - | $169.45M(+24.1%) |
| Jun 2014 | - | $136.50M(+30.5%) |
| Mar 2014 | - | $104.60M(+16.3%) |
| Dec 2013 | $89.96M(-57.6%) | $89.96M(-11.7%) |
| Sep 2013 | - | $101.91M(+10.4%) |
| Jun 2013 | - | $92.31M(-29.8%) |
| Mar 2013 | - | $131.54M(-38.1%) |
| Dec 2012 | $212.40M(+48.9%) | $212.40M(+8.8%) |
| Sep 2012 | - | $195.16M(+17.9%) |
| Jun 2012 | - | $165.58M(+4.1%) |
| Mar 2012 | - | $159.10M(+11.5%) |
| Dec 2011 | $142.67M(+27.7%) | $142.67M |
| Dec 2010 | $111.70M | - |
FAQ
- What is Globus Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Globus Medical?
- What is Globus Medical annual cash & cash equivalents year-on-year change?
- What is Globus Medical quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Globus Medical?
- What is Globus Medical quarterly cash & cash equivalents year-on-year change?
What is Globus Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of GMED is $784.44M
What is the all time high annual cash & cash equivalents for Globus Medical?
Globus Medical all-time high annual cash & cash equivalents is $784.44M
What is Globus Medical annual cash & cash equivalents year-on-year change?
Over the past year, GMED annual cash & cash equivalents has changed by +$317.15M (+67.87%)
What is Globus Medical quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GMED is $461.27M
What is the all time high quarterly cash & cash equivalents for Globus Medical?
Globus Medical all-time high quarterly cash & cash equivalents is $784.44M
What is Globus Medical quarterly cash & cash equivalents year-on-year change?
Over the past year, GMED quarterly cash & cash equivalents has changed by +$107.20M (+30.28%)